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CASE REPORT

Pancreatic Cancer with a Skeletal Muscle Metastasis - A
Case Presentation and Literature Review
Nicholas Spetsieris a,*, Gayatri Bobba a, Priyanka Bhandari a, Samir Patel b,
Zubin Tharayil a, Ravi Gupta a
a
b

Department of Internal Medicine, Long Island Community Hospital, Patchogue, NY, USA
New York Cancer and Blood Specialists, Patchogue, NY, USA

Abstract
One-half of patients with newly diagnosed pancreatic cancer will have metastatic disease at the time of diagnosis,
mainly due to its non-speciﬁc initial clinical presentation which includes abdominal pain, dyspepsia, weight loss, bowel
habit changes, jaundice and pruritus. The signs, symptoms and stage of the disease at initial diagnosis depends on the
origin of the primary tumor, with tumors of the head presenting earlier with obstructive symptoms while tumors of the
body/tail are often diagnosed at an advanced stage due to their non-speciﬁc presentation. The most common sites of
metastasis are the lymph nodes, liver, lung, and peritoneum. The presence of metastatic disease in the skeletal muscles is
a rare manifestation of pancreatic cancer and has been described in a limited number of cases. We report the case of a
pancreatic cancer patient with a solitary muscle lesion as the only site of extra-nodal metastasis upon initial presentation.
Keywords: Pancreatic cancer, Metastatic pancreatic cancer, Skeletal muscle metastasis, Solitary skeletal muscle lesion,
Isolated skeletal muscle metastasis, Metastatic pancreatic adenocarcinoma, Poorly differentiated muscle lesion

1. Background

P

ancreatic cancer is the 11th most commonly
diagnosed malignancy in the United States and
accounted for an estimated 48,220 deaths in 2021.
The aggressive nature and high mortality of the
disease are underlined by an average 5-year relative
survival rate of 10.8%.1 The most common sites of
metastasis are non-regional lymph nodes, liver,
lung and peritoneum.2 Skeletal muscle metastases
are rarely present in patients with pancreatic cancer.

2. Objective
To report a patient with pancreatic cancer who
presented with a rare skeletal muscle metastasis.

3. Case presentation
A 61-year-old Caucasian male with a past medical
history of GERD presented to the emergency room
with three weeks of left upper quadrant abdominal

pain associated with dyspepsia, unintentional weight
loss of approximately 30 pounds, and non-speciﬁc
loose brown bowel movements which were nonwatery and not suggestive of steatorrhea. The
abdominal pain radiated to his ipsilateral ribcage,
back, and left leg; the pain worsened with ambulation
and awakened him from his sleep. He denied blood
in his stool, nausea, vomiting, fever, chills, night
sweats and pruritus. He had a routine screening colonoscopy three years ago without abnormal ﬁndings. He was a current smoker (20 pack-years),
reported moderate alcohol consumption and a history of recreational cocaine and marijuana use.
On presentation, his vital signs were: blood pressure 140/91 mmHg, heart rate 122/minute, respiratory rate 18/minute, temperature 99.7  F, and oxygen
saturation 99% on room air; he weighed 68 kg and a
body mass index of 17.43 kg/m2. He was frailappearing without jaundice or temporal wasting. His
abdomen had tenderness and dullness to percussion
in the epigastrium and left upper quadrant, without
palpable masses; bowel sounds were present.
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Tenderness was also noted over the left sacroiliac
joint, the left paraspinal region and the left rib cage.
Straight leg raise test was positive on the left side,
while no focal motor or sensory deﬁcits were
appreciated. The remainder of the physical examination was unremarkable.
Initial laboratory ﬁndings were notable for WBC
11.41 k/uL, hemoglobin 15.7 g/dL, platelets 203 k/uL,
total bilirubin 1.8 mg/dL, direct bilirubin 0.8 mg/dL,
ALP 175 U/L, AST 45 U/L, ALT 18 U/L, and lipase 40
U/L. A CT of the abdomen and pelvis with contrast
revealed: a 9.8 cm  12.1 cm heterogeneous necrotic
left upper quadrant mass (Fig. 1), most likely originating from the pancreas, completely obscuring the
pancreatic body and tail and also inﬁltrating the
spleen and the gastric fundal wall; a splenic vein
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thrombosis was also present; and the pancreatic
head was grossly unremarkable. Furthermore, a 5.6
cm  4.7 cm heterogeneous hypodense left iliac
intramuscular mass was found (Fig. 2). The patient
was admitted for further work-up of the abdominal
mass and was started on anticoagulation for the
thrombosis.
CT scans of the brain and lumbar spine, and CT
angiography of the chest, were negative for any
signiﬁcant pathology. Carcinoembryonic antigen
(CEA) and CA 19-9 were 11.3 ng/mL and 159 U/mL,
respectively. A subsequent MRI of the abdomen
with and without contrast conﬁrmed the presence of
the abdominal mass and favored a pancreatic primary. An MRCP revealed no evidence of intrahepatic or extrahepatic biliary dilatation and the
pancreatic duct was normal in caliber. MRI of the
brain with and without contrast showed no signiﬁcant abnormal ﬁndings. A percutaneous CT-guided
core biopsy and aspiration of the left iliac muscle
mass was performed. Cytologic examination of the
aspirate revealed abundant necrotic debris and
sparse signiﬁcantly atypical cells, suspicious for a
neoplastic process. Pathologic examination of the
core biopsy specimen demonstrated poorly differentiated carcinoma with necrosis (Fig. 3a). On
immunohistochemistry studies the specimen was
positive for pancytokeratin (Fig. 3b), Cam 5.2
(Fig. 3c), Vimentin, and CK7; the sample was
negative for leukocyte common antigen, HMB45/
MART-1, S-100, SOX10, prostate speciﬁc antigen,
ERG, CK7, CK20, thyroid transcription factor-1,
CDX-2, p40, PAX-8, synaptophysin and desmin. The
primary site could not be established from histopathologic and immunohistochemistry studies.
The remainder of his hospital course was unremarkable and the patient was discharged with
oncology follow-up. An outpatient ﬂuorodeoxyglucose positron emission tomography (F18-FDG
PET) scan showed FDG-avid masses in the left
abdomen (representing the primary pancreatic
tumor) and left gluteal muscles with areas of necrosis as well as enhancing pelvic nodes. He was
subsequently referred to radiation oncology for
palliative therapy.

4. Discussion

Fig. 1. CT abdomen and pelvis with contrast demonstrating a necrotic
9.8 cm  12.1 cm left upper quadrant mass which completely obscures
the pancreatic body and tail and inﬁltrates the spleen and gastric fundal
wall (arrows). a. Axial Image; b. Coronal Image.

Skeletal muscle metastasis is a rare entity per se,
with post-mortem studies reporting a varying incidence of 0.03e17.5%, while the incidence in clinical
studies ranges between 0.01 and 0.16%.3e5 From a
retrospective review of the literature and the authors’ institutional database, Surov et al reports a
cohort of 461 patients with muscle metastases. The
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Fig. 2. CT abdomen and pelvis with contrast demonstrating a heterogeneous hypodense 5.6 cm  4.7 cm mass within the left iliac muscle
(arrows). a. Axial Image; b. Coronal Image.

most common primary sites of origin for these lesions were lung (25.1%), gastrointestinal (21.0%) and
urological tumors (13.2%). This study is in line with
two case series of 15 and fewer patients, in which
lung and gastrointestinal tumors were more likely to
be the primary sites.6,7
Metastatic disease to the skeletal muscles originating from the pancreas has been previously reported. To our knowledge, after an extensive review
of the literature, a total of 10 cases have been
described since 1894, including cases found either
only on autopsy or with clinical involvement of
skeletal muscles by the disease.8 These cases
include metastasis to the right gluteus maximus
muscle,8 metastases to the peroneal muscles in the
calf and the anterior compartment muscles in the
thigh and shoulder.9 A case of thoracic wall metastasis has been described, with lesions located in the
trapezius, teres minor, and infraspinatus muscles10

as well as a rare case of metastasis to the medial
masseter and pterygoid muscles.11
As reported in a systematic review of imaging
characteristics found in skeletal muscle lesions,
among 281 patients with skeletal muscles metastases, the majority presented on CT with intravenous
contrast as abscess-like lesions with central lowattenuation and rim-enhancement, followed by homogeneous contrast-enhanced lesions, hypodense
lesions (as in our case), and more infrequently isodense.12 Interestingly, between the four studies
reviewed in this systematic review that described
skeletal muscle metastases as hypodense, two are
focused on lesions in the iliopsoas muscle as reported in our case.13,14
The pathophysiologic mechanism of distant metastatic spread in pancreatic cancer is mainly hematogenous, via the arterial or venous route, and
through the lymphatic system. The abundant
vascular supply of skeletal muscles may account for
a possible arterial or venous dissemination and
homing of cancer cells to the muscle tissue,
although this process is mainly governed by
endogenous factors such as the cancer cells' driver
gene mutations as well as transcriptional and posttranscriptional changes. This is depicted by the rare
presentation of skeletal muscle metastases in
pancreatic cancer. Venous spread, via the portal
vein, leads to liver metastases which is the most
common presentation of metastatic disease in
pancreatic cancer.10,15 Pelvic and abdominal tumors
have also been described to spread via the vertebral
venous (Batson's) plexus, which communicates with
the inferior vena cava and the mesenterial venous
system.4 Lymphatic spread has been considered an
early event in tumor development and may be
implicated in skeletal muscle metastases, with initial
involvement of the sentinel lymph node. Inﬁltrated
lymph nodes may act as a “ﬁrst stop” for cancer cells
preparing to migrate to other organs.15 Perineural
invasion has been hypothesized as a possible
explanation of muscle metastasis in a patient with
bladder cancer; however, in this case, the involved
nerves were evident on MRI and PET scans.16
In our case the exact route of dissemination
cannot be deﬁnitively determined. Histopathologic
ﬁndings do not include vascular or perineural invasion of the tumor in the microscopic level. Imaging ﬁndings (CT scan and PET/CT) do not prove
gross invasion of an arterial structure, nerve or
direct invasion of the left iliac muscle. The splenic
vein thrombosis seen on CT scan may be indicative
of likely venous spread of the tumor or may be a
result of the hypercoagulable state caused by the
cancer itself. The FDG-avid pelvic lymph nodes may
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Fig. 3. Pathologic examination of the muscle mass biopsy specimen. a. Hematoxylin and eosin stain (100x magniﬁcation): poorly differentiated
carcinoma with necrosis; b. Immunohistochemistry stain for Pancytokeratin (100x magniﬁcation) positive; c: Immunohistochemistry stain for Cam
5.2 (100x magniﬁcation) positive.

be signiﬁcant for lymphatic spread of the cancer to
the skeletal muscle. However, the presence of
enlarged and FDG-avid intra-abdominal lymph
nodes would be expected on conventional imaging
and PET/CT scan indicative of this process. We may
hypothesize, given the limitations described above,
that the tumor metastasized hematogenously via the
venous route or via the lymphatics.
Primary pancreatic tumors most commonly arise
from the head of the pancreas (approximately 70%),
while differences in clinical presentation and prognosis have been noted between tumors arising from
the head and the body/tail of the pancreas.
Pancreatic head masses cause obstructive phenomena and manifest early upon the progression of the
disease with characteristic signs and symptoms such
as nausea, vomiting, jaundice, and abdominal pain.
Head/tail tumors are commonly identiﬁed at a more
advanced stage of the disease and therefore were
historically considered to have a worse prognosis.17,18 Notably, a recent retrospective study
identiﬁed an association between location of the
tumor in the body/tail of the pancreas and worse
prognosis, irrespective of stages and other prognostic factors, thus concluding that there may be a
biologic difference between these two cancer
types.18 In our case the primary tumor completely
obscured the body and tail of the pancreas while the
head appeared unremarkable on conventional imaging. This presentation is in line with the advanced
disease stage on diagnosis and the aggressive nature
of the disease.
Our patient's presentation, with only a skeletal
muscle metastasis as evidence of extra-nodal metastatic disease, is unique for pancreatic cancer. On
histopathology, the skeletal muscle lesion appeared
poorly differentiated with marked necrosis, while
immunohistochemistry revealed the epithelial

component, in line with the radiologic diagnosis of
an intra-abdominal malignancy originating from
the pancreas. The absence of frank histologic
conﬁrmation of pancreatic adenocarcinoma as the
primary malignancy in our case is a limitation of
this report. Given the aggressive potential of the
tumor which drove such an unusual distant spread
route, a poorly differentiated phenotype of the
metastatic lesion was expected. Nonetheless, the
pancreatic origin of the tumor evidenced in CT and
MRI as well as the epithelial markers detected in
the metastatic site sample allow for a safe interpretation of the disease as adenocarcinoma with
the pancreas as the primary site.

5. Conclusion
We report a rare case of a patient diagnosed with
pancreatic cancer, with a solitary muscle lesion as
the only extra-nodal metastatic site of the disease
upon initial presentation. Conventional imaging
with CT proved adequate in the characterization of
the lesion. Importantly, a highly aggressive malignancy such as pancreatic cancer may present with
metastatic lesions to rarely reported sites. Therefore,
it is imperative for physicians to familiarize themselves with the various presentations of nonobstructive pancreatic cancer and to investigate any
suspicious clinical ﬁndings with imaging and
further histopathologic workup.
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